é²è¡åéã®èªç©ºãæµ·äºãæè¡éçºããµã¤ãã¼ãæ å ±åéé¢é£ã®è©±é¡ãåºãæ±ã£ã¦ãã¾ãã
é²è¡åéã®èªç©ºãæµ·äºãæè¡éçºããµã¤ãã¼ãæ å ±åéé¢é£ã®è©±é¡ãåºãæ±ã£ã¦ãã¾ãã
ï¼æï¼æ¥ã ç±³å ±åå ã¯æ°åã³ããã¦ã¤ã«ã¹ãä¸å½ã®æ¦æ¼¢ã¦ã¤ã«ã¹ç 究æããæµåºãã証æ ã大éã«ããã¨ã®å ±åæ¸ãå ¬è¡¨ããã åçã¯ã¦ã¤ã«ã¹ã®ã¤ã¡ã¼ã¸ãï¼ï¼ï¼ï¼å¹´ï¼ææ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼/NEXU Science Communicationï¼ ï¼»ã¯ã·ã³ãã³ãï¼æ¥ããã¤ã¿ã¼ï¼½ - ç±³å ±åå ã¯ï¼æ¥ãæ°åã³ããã¦ã¤ã«ã¹ãä¸å½ã®æ¦æ¼¢ã¦ã¤ã«ã¹ç 究æããæµåºãã証æ ã大éã«ããã¨ã®å ±åæ¸ãå ¬è¡¨ããã
ãæ¦æ¼¢ç 究æããã³ããã¦ã¤ã«ã¹ãæµåºããã®ãä¸å¯è½ã ã¨ãã話ã§ã¯ããã¾ããããããèªç¶ããç±æ¥ããå¯è½æ§ãæã大ããã¨ã¿ã¾ããã æ°åã³ããã¦ã¤ã«ã¹ã®èµ·æºããããè«äºãç¶ãä¸ã§ãçºçå°ã®çããåãã¦ããä¸å½ã»æ¦æ¼¢ã¦ã¤ã«ã¹ç 究æã§å¤åããå¤å½äººç 究å¡ã¯ãã®ããã«ä¸»å¼µããã ãã«ã¼ã ãã¼ã°ã¯ï¼ï¼æ¥ãæ¦æ¼¢ç 究æã§ï¼ï¼ï¼ï¼å¹´ï¼ï¼æã¾ã§å¤åãããªã¼ã¹ãã©ãªã¢åºèº«ã®ããã¨ã«ã»ã¢ã³ãã¼ã½ã³ç 究å¡ã®çºè¨ãä¼ãããæ¦æ¼¢ç 究æã§åããå¤å½äººç 究å¡ã¨ãã¦ã¯ãæå¾ã®ï¼äººãã ã æ°åã³ããã¦ã¤ã«ã¹ã®çºçã¯ï¼ï¼ï¼ï¼å¹´ï¼ï¼æï¼ï¼æ¥ã«ä¸çã§åãã¦ä¸å½ã§å ±åãããããã¢ã³ãã¼ã½ã³æ°ã¯ææè å ±åã®ï¼ã«æåã¾ã§ããã§åãã¦ãããç¾å¨ã¯ã¡ã«ãã«ã³ã®ãã¼ã¿ã¼ã»ããã¼ãã£ææå ç«ç 究æã§åãã¦ããã ã¢ã³ãã¼ã½ã³æ°ã¯ãæ¦æ¼¢ç 究æã¯é常ã®å®é¨å®¤ã¨åãæ¹å¼ã§éå¶ãããä¸è¬çãªç 究æã ã£ããã¨ããªãããããååã®çå®ã¨æªæ²ãããæ å ±ã®ãã
è±å½ã®ã±ã³ã大å¦ãè¡ã£ãæ°åã³ããã¦ã¤ã«ã¹ã®çºçææã«é¢ãã調æ»ã«ããã¨ãã¦ã¤ã«ã¹ã®ææä¾ãä¸å½ã®æ¦æ¼¢ã§åãã¦ç¢ºèªããããããï¼ã«æã»ã©åãã¦ã¤ã«ã¹ãæ¢ã«ä¸å½å½å ã§åºããå§ãã¦ããå¯è½æ§ããããã¨ãåãã£ããåçã¯ãã³ããã¦ã¤ã«ã¹ã®è¿ éãªææ¡ã®ããã®æ°ããå¾æ¶²æ¤æ»æ¹æ³ã§è§£æä¸ã®æ§åãï¼ï¼ï¼ï¼å¹´ï¼ï¼æï¼ï¼æ¥ã«ããªã§æ®å½±ãï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼ï¼Benoit Tessierï¼ ï¼»ä¸æµ·ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - è±å½ã®ã±ã³ã大å¦ãè¡ã£ãæ°åã³ããã¦ã¤ã«ã¹ã®çºçææã«é¢ãã調æ»ã«ããã¨ãã¦ã¤ã«ã¹ã®ææä¾ãä¸å½ã®æ¦æ¼¢ã§åãã¦ç¢ºèªããããããï¼ã«æã»ã©åãã¦ã¤ã«ã¹ãæ¢ã«ä¸å½å½å ã§åºããå§ãã¦ããå¯è½æ§ããããã¨ãåãã£ãã ã±ã³ã大å¦ã¯ãå¦è¡èªãPLOS Pathogensãã«æ²è¼ãããè«æã§ãæ°åã³ããã¦ã¤ã«ã¹ãçºçããã®ã¯ï¼ï¼ï¼ï¼å¹´ï¼ï¼æåæ¬ããï¼ï¼æä¸æ¬ã«ããã¦ã¨æ¨å®ãçºçææã¨ãã¦ã¯ï¼ï¼æï¼ï¼æ¥
ï¼ãã³ãããã¯çºçå¾æ©ã段éã§ãåä¸ã®é°è¬èª¬ãã¨ããã¦ããæ°åã³ããã¦ã¤ã«ã¹ã®ãç 究ææµåºèª¬ããããã¸æ¥ã¦æ¥ã«è¦ç´ããã¦ããã®ã¯ãä¸å½ã®èª¬æãããããã¨æããä¸çåå°ã®ã¢ããã¥ã¢ãããã¦ã¼ã¶ã¼ããã¼ã ãçµãã§å¦å®ããããæ°äºå®ãç§å¦çã¨å¤§ã¡ãã£ã¢ã«çªãã¤ããããã ï¼ æ°åã³ããã¦ã¤ã«ã¹ææçã®ãã³ãããã¯ï¼ä¸ççãªå¤§æµè¡ï¼ã¯ä¸å½ã»æ¦æ¼¢ã®ç 究æããæéãã§ã¦ã¤ã«ã¹ãæµåºãã¦å¼ãèµ·ããããââããã¯ã¤ãæè¿ã¾ã§ãªã«ãã»ã©ã¤ãï¼æ°å³ç¿¼ï¼çãªé°è¬è«ã¨ãã¦ããããç¡è¦ããã¦ãã主張ã ã ã¯ã·ã³ãã³ã»ãã¹ãã¯2020å¹´åãããå°é家ãä½åº¦ããã®èª¤ãã証æããé°è¬è«ããå·æã«è¸ãè¿ãã¦ãããã¨ãã¦ããã ã»ã³ããã³ä¸é¢è°å¡ãæ¹å¤ãCNNã¯ãé°è¬è«ã誤æ å ±ãä¿¡ãã¦ããå人ã家æã説å¾ããæ¹æ³ããä¼ãããã¥ã¼ã¨ã¼ã¯ã»ã¿ã¤ã ãºããé主æµã®èª¬ãæ±ããããå ¬å ±æ¾éã®NPRããç 究æã®äºæ ã§æµåºããã¨ãã説ã¯èå½ã ã¨
ï¼æï¼ï¼æ¥ãä¸å½ãæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ãå ¬è¡¨ããæ°ã«æåã®ï¼ï¼ï¼ï¼å¹´ï¼ï¼æãæ¦æ¼¢ã¦ã¤ã«ã¹ç 究æã«æå±ããç 究è ï¼äººãç é¢ã§ã®æ²»çãå¿ è¦ã«ãªãã»ã©ã®ä½èª¿ä¸è¯ã訴ãã¦ãããåçã¯åç 究æã®å¤ã®è¦åå¡ããï¼ææ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼/Thomas Peterï¼ ï¼»ã¯ã·ã³ãã³ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - ä¸å½ãæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ãå ¬è¡¨ããæ°ã«æåã®ï¼ï¼ï¼ï¼å¹´ï¼ï¼æãæ¦æ¼¢ã¦ã¤ã«ã¹ç 究æã«æå±ããç 究è ï¼äººãç é¢ã§ã®æ²»çãå¿ è¦ã«ãªãã»ã©ã®ä½èª¿ä¸è¯ã訴ãã¦ãããç±³ç´ã¦ã©ã¼ã«ã¹ããªã¼ãã»ã¸ã£ã¼ãã«ï¼ï¼·ï¼³ï¼ªï¼ããããã¾ã§å ¬è¡¨ããã¦ããªãã£ãç±³æ å ±æ©é¢ã®å ±åæ¸ãå¼ç¨ãã¦ï¼ï¼æ¥ã«å ±ããã WSJã«ããã¨ãå ±åæ¸ã«ã¯å½±é¿ãåããç 究è ã®æ°ãä½èª¿ä¸è¯ã«ãªã£ãææãéé¢åæ°ã«é¢ããæ°ããªè©³ç´°æ å ±ãå«ã¾ãã¦ãããæ°åã³ããã¦ã¤ã«ã¹ãåç 究æããæµåºããå¯è½æ§ã«ã¤ãã¦ããã詳細ãªèª¿æ»ãæ±ãã声ãé«ã¾ãå¯è½
ï¼ï¼£ï¼®ï¼®ï¼Â æ°åã³ããã¦ã¤ã«ã¹ã®çºçæºãæ¢ãããä¸å½æ¹åçã®æ¦æ¼¢å ¥ãããä¸çä¿å¥æ©é¢ï¼ï¼·ï¼¨ï¼¯ï¼èª¿æ»å£ã®èª¿æ»ã§ãï¼ï¼ï¼ï¼å¹´ï¼ï¼æã«ç¢ºèªãããæ¦æ¼¢ã§ã®ææã¯ãããã¾ã§èãããã¦ããããã¯ããã«åºç¯ã«åãã§ããå åããããã¨ãåãã£ãã調æ»å£ã¯ãä¸å½æ¿åºãã¾ã 許å¯ãã¦ããªãæ°åä¸ä»¶ã®è¡æ¶²ãµã³ãã«ãç·æ¥èª¿æ»ãããæåã ã æ¦æ¼¢ããã¹ã¤ã¹ã«æ»ã£ã調æ»å£é·ã®ãã¼ã¿ã¼ã»ãã³ã»ã¨ã³ãã¬ã¯æ°ãCNNã®ã¤ã³ã¿ãã¥ã¼ã§èªã£ãã¨ããã«ããã¨ã調æ»å£ã¯ä»ååãã¦ãæ¦æ¼¢ã§ã¯ï¼ï¼ï¼ï¼å¹´ï¼ï¼æã®æç¹ã§æ¢ã«ï¼ï¼ç¨®é¡ä»¥ä¸ã®ã¦ã¤ã«ã¹æ ªãåå¨ãã¦ãããã¨ãçªãæ¢ããã ããã§ãæ°åã³ããã¦ã¤ã«ã¹ãï¼ï¼æä¸æ¬ã«åãã¦å ¬å¼ã«ç¢ºèªããããã£ã¨åããä¸å½å½å ã§æ¡æ£ãã¦ããå¯è½æ§ãããã¨ããæ¸å¿µãä¸å±¤å¼·ã¾ã£ããã¨ã³ãã¬ã¯æ°ã¯ãããã®ã¦ã¤ã«ã¹ã¯ï¼ï¼æã«æ¦æ¼¢ã§åºãåºåã£ã¦ãããããã¯æ°ããçºè¦ã ãã¨ææããã 調æ»å£ã¯ã¾ããä¸å½å½å±ãæåã®æ
ä¸å½ã§æ°åã³ããã¦ã¤ã«ã¹ã®ææãï¼ï¼ï¼ï¼å¹´ï¼æããåºãã£ã¦ããå¯è½æ§ãææãã調æ»çµæããã¼ãã¼ãã»ã¡ãã£ã«ã«ã»ã¹ã¯ã¼ã«ï¼ãã¼ãã¼ã大å¦å»å¦å¤§å¦é¢ï¼ãçºè¡¨ãããåçã¯æ°åã³ããã¦ã¤ã«ã¹ã®ã¤ã¡ã¼ã¸ç»åï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼/ NEXU Science Communicationï¼ ä¸å½ã§æ°åã³ããã¦ã¤ã«ã¹ã®ææã2019å¹´8æããåºãã£ã¦ããå¯è½æ§ãææãã調æ»çµæããã¼ãã¼ãã»ã¡ãã£ã«ã«ã»ã¹ã¯ã¼ã«ï¼ãã¼ãã¼ã大å¦å»å¦å¤§å¦é¢ï¼ãçºè¡¨ããã 調æ»çµæã¯ãå°é家ã«ããæ¤è¨¼ï¼æ»èªï¼ãã¾ã åãã¦ããªããæ°åã³ããææçã¯ãæ¨å¹´çµç¤ã«æ¹åçæ¦æ¼¢å¸ã§çºçããã¨èãããã¦ããã ä¸å½å¤åçã®å ±éå®ã¯ããã¼ãã¼ã大ã®ç 究çµæã«ã¤ãã¦ãã°ããã¦ãããã¨æ¹å¤ããå°é家ãã¯çºçææã«ã¤ãã¦èª¬å¾åã®ãããã¼ã¿ã示ããã¦ããªãã¨ã³ã¡ã³ãããã ãã¼ãã¼ãã»ã¡ãã£ã«ã«ã»ã¹ã¯ã¼ã«ã¯ãæ¦æ¼¢å¸ã®ç é¢é§è»å ´ã®è¡æç»åããã¤ã³ã¿
ï¼»å京ãï¼æ¥ããã¤ã¿ã¼ï¼½ - æ°åã³ããã¦ã¤ã«ã¹å¤§æµè¡ã®éæºå°ã¨ãªã£ãä¸å½æ¹åçã®æ¦æ¼¢å¸ã¯ãä¸çã®ä»ã®é½å¸ã«å é§ãã¦å°éã解é¤ããããä¸å½èªèº«ã ãã§ãªããåå½ã®å ¬è¡è¡çå°é家ããã®å°ãè¾¼ããæåä¾ã¨ãã¦ç§°è³ãã¦ããããããã¯ãã¦ã³ã¾ã§ã®éã®ãã¯ç°¡åã§ã¯ãªãã£ãã ãã¤ã¿ã¼ã¯ãã¾ããªãã¼ã¿ãå ¬å¼è¨é²ã«å½ããã¨ã¨ãã«ãæ¦æ¼¢ã®å¸å½å±è ãä½æ°ãç§å¦è ãªã©æ°å人ã«ã¤ã³ã¿ãã¥ã¼ããããããããè¦ãã¦ããã®ã¯ãåé¡ããªããªãç´è¦ã§ããªãã£ãæ¦æ¼¢å¸å½å±ã¨ãäºæ ã®æ·±å»ããç®ã®å½ããããæ ã¦ã¦å¼·æ¨©ãçºåãã¦ããä¸å¤®ã®å§¿ã ã£ãã
ä¸å½ã®ç¿è¿å¹³å½å®¶ä¸»å¸ãå é±ãå°æ¹å½å±ã®é«å®ã«å¯¾ããæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ãé²ãåãçµã¿ã¯è¡ãéãã¦ãããå½å çµæ¸ã«æªå½±é¿ãããããã¦ããã¨è¦åãããã¨ãï¼æï¼ï¼æ¥ãé¢ä¿çã®è©±ã§æããã«ãªã£ããåçã¯ï¼ï¼æ¥ãä¸æµ·ã§æ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼ï¼Aly Songï¼ ï¼»å京ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - é¢ä¿çã«ããã¨ãä¸å½ã®ç¿è¿å¹³å½å®¶ä¸»å¸ã¯å é±ãå°æ¹å½å±ã®é«å®ã«å¯¾ããæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ãé²ãåãçµã¿ã¯è¡ãéãã¦ãããå½å çµæ¸ã«æªå½±é¿ãããããã¦ããã¨è¦åããããã®æ°æ¥å¾ã«ä¸å½æ¿åºã¯çµæ¸ã¸ã®å½±é¿ã軽æ¸ããæªç½®ãçºè¡¨ããã é¢ä¿çï¼äººããã¤ã¿ã¼ã«æããã«ããã¨ããã«ããã¨ãç¿æ°ã¯æææ¡å¤§ã«é¢ããå½å®¶çºå±æ¹é©å§å¡ä¼ï¼çºæ¹å§ï¼ãªã©ã®å ±åæ¸ãè¦ãå¾ãï¼æ¥ã«éãããå ±ç£å æ¿æ²»å±å¸¸åå§å¡ä¼ã®ä¼åã§å°æ¹å½å±è ã«å¯¾ããæææ¡å¤§é²æ¢ã®ããã®ä¸é¨ã®æªç½®ã¯çµæ¸ã«æªå½±é¿ãããããã¦ããã¨ææããã
ACL決åã®ç¥ããããèå°è£ââãã¼ã ããã¼ã¸ã£ã¼ãèªãUAEæ¦è¨ãæ¥æ¬ãµãã«ã¼ã»ãã¤ããªãã£ãªãã¼ãã 09-19 15:08
ä¸çã§ææãåºãã£ã¦ããæ°åã³ããã¦ã¤ã«ã¹ã«ã¤ãã¦ãä¸å½å½å¶ã®æ°è¯ç¤¾éä¿¡ã¯çµå£ææï¼ç³å£ææï¼ã®å¯è½æ§ãããã¨å ±ããã å ±éã«ããã°ãã¦ã¤ã«ã¹ã®éºä¼ç©è³ªãæ£è ã®ä¾¿ãç´è ¸ããæ¡åããæ¤ä½ã§è¦ã¤ãã£ããæ¹åçã®æ¦æ¼¢å¤§å¦äººæ°ç é¢ã¨ä¸å½ç§å¦é¢æ¦æ¼¢ã¦ã¤ã«ã¹ç 究æã®ç 究è ãçºè¦ãããã®ã§ãä¸é¨ã®æ£è ã®åæçç¶ãçºç±ã§ã¯ãªããä¸ç¢ã§ãããã¨ã«çç®ããã¨ããã ããã¯æ£è ã®ããããããã¿ããã®é£æ²«ï¼ã²ã¾ã¤ï¼ææã ãã«éãããªãå¯è½æ§ã示ããå»å¸«ãã¯æ°åã³ããã¦ã¤ã«ã¹ã®æ£è ãè¦åããéã«èºçæ£è ããæ¡åããå¼å¸å¨ç³»ã®ãµã³ãã«ãéè¦ãã¦ããããæææºã¨ãã¦ä¸ç¢ã®çç¶ãç¡è¦ãã¦ãããããããªãã¨ããã«ã¼ã ãã¼ã°ã»ãã¥ã¼ã¹ã¯ï¼æ¥å ±ãã¦ããã éçæ¥æ§å¼å¸å¨çå群ï¼ï¼³ï¼¡ï¼²ï¼³ï¼ã®åå ã¨ãªãã¦ã¤ã«ã¹ã§ãæ£è ã®ç´10ã¼20ï¼ ãä¸ç¢ã®çç¶ã訴ãã¦ããã
æ¬ããã°ã1/21ããåãä¸ããæ°åã³ããã¦ã£ã«ã¹ã ããæããã¦ããããã®2é±éå¼±ã§ä¸å½ã®å¹´å°éã¨çµæ¸æ´»ååæ¢ã¨ãã大é¨ãã«ãªã£ãããããã§æ§æ£æã®ä¼å ´ä¸ã«æ ªãå¦åã§ããªãã¾ã¾ãã³ãããã¯ã«ãªã£ãããã¾ã£ããã®ã§ã¯ãªããã¨ããé¦æ¸¯æ ªåå è ã®è¦æå¿ã¯æ£ãããä¸å½ã»é¦æ¸¯æ ªãä¼å ´ãã¦ããéã«ã¨ãã§ããªããã¨ã«ãªã£ããç±³å½ã§ä¸å ´ããä¸å½æ ªETF MCHIã¯ä¸æ10%以ä¸ä¸è½ãããé¦æ¸¯æ ªã¯æ¬åæ ªããä¸è¶³å ã«ãªã¼ãã³ããããæ°æ¥ããã¦10%ã®ããã¼ãã¦ã³ãæ¼ãããããã¦æå¾ã«ä¼å ´æããè¿ããä¸æµ·æ ªã¯å·¨å¤§ãªçªã空ãã¦ä¸è½ããããããããã¯æ¿çæå¾ ãªã©ã§ä½ã¨ãæã¡å ªãã¦ããã ä¾ç¶çè ã¯å»å¦ã«ã¯å ¨ãæãããªããããã®è¨äºå ¨ä½ãå ¨ãã®æ¨æ¸¬ã«ãããªãããã ãã ãæããã«ãªã£ãä¸å½çºæ°åã³ããã¦ã£ã«ã¹æµè¡ã®å ¨ä½åãæ¸ãã¦ã¿ããã¨æãã BBCãè¦ããã¦å ±éããããã«ãã³ã¦ã¢ãªã¹ã¼ãã¯ä¸å½ã®é£ã¹ç©ã§ã¯ãªãã£ãï¼ã
京é½åºã«ä½ãä¸å½ç±ã®20代ã®ç·æ§ãæ°åã³ããã¦ã¤ã«ã¹ã«ææãã¦ãããã¨ãæ°ãã«ç¢ºèªããã¾ãããç·æ§ã¯çºçããï¼é±é以å ã«ä¸å½ã¸ã®æ¸¡èªæ´ã¯ãªããå¤åå ã§ä¸å½ããã®è¦³å 客ãæ¥å®¢ããã¨è©±ãã¦ããã¨ãããã¨ã§ãã ç·æ§ã¯çºç±ã¨ããã®çç¶ãåºã¦å æ25æ¥ããä»äºãä¼ã¿ãï¼æ¥ãã¦ã¤ã«ã¹æ¤æ»ãè¡ã£ãã¨ããææã確èªãããã¨ãããã¨ã§ãã ç·æ§ã¯ç¾å¨ã¯ç±ã¯ãªãããããããã¾ã£ã¦ãã¦ããã¨ãããã¨ã§ãã åçå´åçã«ããã¾ãã¨ãç·æ§ã¯çºçããï¼é±é以å ã«ä¸å½ã¸ã®æ¸¡èªæ´ã¯ãªããå¤åå ã§ä¸å½ããã®è¦³å 客ãï¼æ¥300人ç¨åº¦è¨ªããåºã§æ¥å®¢ãã¦ããã¨ãããã¨ã§ãã ä¸ã«ã¯æ¹åçããæ¥ãã¨æããã客ãå«ã¾ããï¼ã¡ã¼ãã«ä»¥å ã®è¿è·é¢ã§ä¼è©±ããããã¨ãå¤ãã£ãã¨è©±ãã¦ãã¦ãåçå´åçã¯æ¥å®¢ã®éã«ææããå¯è½æ§ãããã¨ãã¦ãã¾ãã ããã§ãå½å ã§ææã確èªããã人ã¯åããã¦35人ã¨ãªãã¾ããã åçå´åçã¯å½å ã§ã¯ç¾å¨ãæµè¡
Knock-On Effects of Chinaâs Coronavirus May Be Worse Than Thought ï¼ä¸çã注ç®ããæ¥ç¯æãã®ä¸å½å¸å ´ã§ãæ ªä¾¡ã¯å¤§ããä¸è½ãããæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ã®çµæ¸ã¸ã®å½±é¿ã¯ãæã£ãããã¯ããã«å¤§ãããã ï¼ æ¥ç¯ï¼æ§æ£æï¼ãæãã2æ3æ¥ã®ä¸å½æ¬åå¸å ´ã¯ãæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ããããä¸å®ããæ¥è½ãåå¼åéããæ°åã§ã¹ãããå®éæãç¶åºããä¸æã¯é£ä¼åã¨æ¯ã¹ã¦8.7ï¼ ä¸è½ããã ãã¾ãã¾ãªè¦å¶ãããä¸å½ã®æ ªå¼å¸å ´ã¯ãä¸å½çµæ¸ã«ããã¦ãã»ã©éè¦ãªå½¹å²ãæããã¦ãã訳ã§ã¯ãªããã ãææè æ°ã2ä¸äººãè¶ ããæ°åã³ããã¦ã¤ã«ã¹ã¸ã®æ¸å¿µãåºãããªãã30å¹´ã¶ãã®ä½æé·ãã¢ã¡ãªã«ã¨ã®é·å¼ã貿ææ¦äºã«ãããä¸å½çµæ¸ã¯ãå°ãªãã¨ãä»å¾æ°ã«æã¯æçããã¡ã¼ã¸ãåãããã¨ã«ãªãããã ã ã»ã¼ä¸çä¸ãæ¥ã ãåã¦ã¤ã«ã¹ã®å½±é¿ãçæãã¦ãããèªç©ºä¾¿
æ°åã®ã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ã«ããä¸å½ã§ã®è´æ»çã¯ãææãæãæ·±å»ãªæ¹åçã»æ¦æ¼¢ã§ã¯ï¼ï¼ è¿ãã«ãªã£ã¦ããä¸æ¹ããã以å¤ã®å°åãè¦ãã¨ããã0.8ï¼ ã«ã¨ã©ã¾ã£ã¦ãã¦ãå°é家ã¯ããæ¦æ¼¢ã§ã¯è»½çã®æ£è ãã«ã¦ã³ãããã¦ãããè´æ»çã¯è¦ããä¸é«ããªã£ã¦ããã¨ã¿ããããã¨è©±ãã¦ãã¾ãã ä¸å½ã®ä¿å¥å½å±ã®ãã¼ã¿ããã¨ã«æ°åã®ã³ããã¦ã¤ã«ã¹ã®è´æ»çãè¦ãã¨ãä¸å½ã§ã¯ããã2.1ï¼ ã§ãããæææ¡å¤§ãæãæ·±å»ãªæ¹åçã»æ¦æ¼¢ã§ã¯ããã4.9ï¼ ã¨ãªã£ã¦ãã¾ãããã®ä¸æ¹ã§ãæ¦æ¼¢ãé¤ããä¸å½ã§ã¿ãã¨ããã0.8ï¼ ã«ã¨ã©ã¾ã£ã¦ãã¾ãã ããã«ã¤ãã¦ï¼·ï¼¨ï¼¯ï¼ä¸çä¿å¥æ©é¢ã§ææç対çãææ®ããçµé¨ã®ããæ±å大å¦ã®æ¼è°·ä»ææã¯ãæ¦æ¼¢ã§ã¯å»çæ©é¢ãæ··ä¹±ãã¦ãããã軽çã®æ£è ãã«ã¦ã³ãããã¦ããªãã£ãããéçæ£è ã¸ã®æ²»çãååè¡ããªãã£ãããã¦ãè´æ»çãé«ããªã£ã¦ããå¯è½æ§ããããã¨ãã¦ãã¾ãã ãã®ä¸ã§ãä»å¾ã¯ãæ¯å¹´ã®ã¤ã³ã
ï¼æï¼æ¥ã次第ã«è©³ç´°ãªå ±éãåºãã«å¾ããæ¨å¹´ï¼ï¼æã«æ°åã³ããã¦ã¤ã«ã¹ã«ããèºçãåãã¦ç¢ºèªãããä¸å½æ¦æ¼¢å¸ã§ãå½å±ã®å¯¾å¿ãã¾ãããæ½å¨çãªå±éºæ§ãé è½ããã¦ããã¨ããç¶æ³ãåãã£ã¦ãããåçã¯æ¦æ¼¢ã®å»çç¾å ´ãè¦å¯ããæå å¼·é¦ç¸ãï¼æï¼ï¼æ¥æ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ãcnsphotoï¼ ï¼»ãã³ãã³ãï¼æ¥ããã¤ã¿ã¼ãBREAKINGVIEWSï¼½ - ä¸å½ãæ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ã¨ããé£æµã«ããã®å¯¾å¿ã¶ãã§åå©ãããã¨ã¯ããæå³ãããå¾ãªããä¸å½æå°é¨ã®æ°åèºçæãè¾¼ã¿ã«åããåãçµã¿ã¯ãã»ã¨ãã©ã®å½ããªãã¨ãå®è¡ã§ããããã強硬ã ãããããä¸ã®è¨ããã¨ã«ç°è°ãå±ããªãã¤ã¨ã¹ãã³ã®æåã¯ãåå段éã§æææ¡å¤§ã許ãã¦ãã¾ã£ããããããäºæ ã¯ãä¸å½ã®å°é ã«ãã£ã¦å©çãè ãããã¦ãã人ãã¡ããä¸å½ã®ç´æãä¿¡ç¨ã§ããªãã¨åãã£ã¦ããè ãã¡ã«ã¨ã£ã¦ãæ ¼å¥½ã®æ»æææã¨ãªã£ã¦ããã ä¸çä¿å¥æ©é¢ï¼ï¼·ï¼¨ï¼¯ï¼ã«ãã
æ¬å½ã®æ··ä¹±ã¯ãããã 誰ããäºæ³ããéããä¹ ã ã«åéããæ¥ç¯ï¼æ§æ£æï¼ä¼ææãã®2æ3æ¥ã®ä¸æµ·æ ªå¼å¸å ´ã¯ãä¸æ9ï¼ ãã®å¤§æ´è½ã¨ãªã£ããããã¯ã¾ã ã¾ã ãæ··ä¹±ã®äºå ã«éããªãã ããã å é±1æ31æ¥ã«ã¯ãã¤ãã«WHOï¼ä¸çä¿å¥æ©é¢ï¼ã®ãããã¹ã»ã¢ããã äºåå±é·ããä¸å½çºã®æ°åã³ããã¦ã¤ã«ã¹ã«é¢ãã¦ãç·æ¥äºæ 宣è¨ãåºããã¨çºè¡¨ãããä¸å½ã¯ä¸ççµæ¸ã®ç´18ï¼ ã®è¦æ¨¡ãå ãã¦ãããè¡çä¸ãçµæ¸ä¸ããä¸çã«ä¸ãããã¤ãã¹ã®å½±é¿ã¯è¨ãç¥ããªãã WHOã¯1æ23æ¥ãé常äºæ 宣è¨ã®çºä»¤ããææå°æ©ã ãã¨ãã¦è¦éã£ã¦ããããããã«ä¸çä¸ããéé£ãåºã¦ãããããããç·æ¥äºæ ã¨è¨ããªããã¦ãWHOã®åå¨ãªã©ã©ãã«ããã®ãï¼ãã¨ããããã ãç§ã¯å é±ãå WHO西太平æ´å°åäºåå±é·ã®å°¾èº«èæ°ã«è©±ãèããããWHOãå¤åã«æ¿æ²»ççµç¹ã§ãããã¨ãç¥ã£ãã ã¡ãªã¿ã«ãããã¹äºåå±é·ã¯ã2016å¹´ã¾ã§ã¨ããªãã¢ã§å¤å大è£ããã¦
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}